TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

Benzinga Logo Benzinga • •By Prnewswire
NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

NewcelX, a Swiss clinical-stage biopharmaceutical company, announced a strategic roadmap update after merging with NLS Pharmaceutics Ltd., focusing on developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

Insights
NCEL   neutral

Company provided a strategic update and investor presentation, indicating ongoing development of therapeutic platforms without explicitly positive or negative financial indicators